[HTML][HTML] Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
R Hawkins, K Fife, M Hurst, M Wang, N Naicker… - BMC cancer, 2020 - Springer
Background Patients with metastatic renal cell carcinoma (mRCC) treated with targeted
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
R Hawkins, K Fife, M Hurst, M Wang, N Naicker… - BMC …, 2020 - search.proquest.com
Background Patients with metastatic renal cell carcinoma (mRCC) treated with targeted
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
RE Hawkins, K Fife, M Hurst, M Wang, N Naicker… - 2020 - christie.openrepository.com
Background: Patients with metastatic renal cell carcinoma (mRCC) treated with targeted
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
R Hawkins, K Fife, M Hurst, M Wang… - BMC …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Patients with metastatic renal cell carcinoma (mRCC) treated with targeted
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
[PDF][PDF] Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
R Hawkins, K Fife, M Hurst, M Wang, N Naicker… - 2020 - scholar.archive.org
Background: Patients with metastatic renal cell carcinoma (mRCC) treated with targeted
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
[PDF][PDF] Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
R Hawkins, K Fife, M Hurst, M Wang, N Naicker… - 2020 - d-nb.info
Background: Patients with metastatic renal cell carcinoma (mRCC) treated with targeted
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
[HTML][HTML] Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
R Hawkins, K Fife, M Hurst, M Wang, N Naicker… - BMC Cancer, 2020 - ncbi.nlm.nih.gov
Background Patients with metastatic renal cell carcinoma (mRCC) treated with targeted
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
[HTML][HTML] Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
R Hawkins, K Fife, M Hurst, M Wang… - BMC …, 2020 - bmccancer.biomedcentral.com
Patients with metastatic renal cell carcinoma (mRCC) treated with targeted systemic
therapies have demonstrated favourable outcomes in randomised controlled trials, however …
therapies have demonstrated favourable outcomes in randomised controlled trials, however …
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK
R Hawkins, K Fife, M Hurst, M Wang, N Naicker… - 2020 - chesterrep.openrepository.com
Background: Patients with metastatic renal cell carcinoma (mRCC) treated with targeted
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK.
R Hawkins, K Fife, M Hurst, M Wang, N Naicker… - BMC Cancer, 2020 - europepmc.org
Background Patients with metastatic renal cell carcinoma (mRCC) treated with targeted
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …